Light Chain Deposition Disease — Trials

Light Chain Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03820817	Rifaximin in Patients With Monoclonal Gammopathy	completed	Phase 1	50	Emory UniversityOTHER	1	May 26, 2026	clinicaltrials
NCT00520767	Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease	completed	Phase 2	35	Barbara Ann Karmanos Cancer InstituteOTHER	1	Dec 22, 2023	clinicaltrials
NCT01849783	Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma	completed	Phase 2	41	Margarida Magalhaes-SilvermanOTHER	1	May 11, 2022	clinicaltrials
NCT01078454	Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Data updated 22 days agoSource updated May 26, 2026source: clinicaltrials